Neuronetics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -663.3% | – | – | – | – | – | – | – | -1,137.6% | – | – | |
| – | +0.8% | +11.3% | -0.9% | -7.7% | -12.9% | +104.3% | -1.1% | -1.7% | -13.4% | -2.9% | -2.1% | – | |
| – | -12.3% | -17.7% | +16.8% | -9.2% | -9.7% | +12.6% | +25.6% | -22.3% | +54.8% | -23.1% | +41.0% | – | |
| – | – | -231.9% | – | -71.3% | -542.1% | – | – | +83.1% | -19.7% | -139.9% | – | – | |
| – | +59.2% | -57.3% | +64.3% | -37.3% | -76.9% | +146.1% | +15.1% | -54.8% | +89.5% | -8.8% | +111.7% | – | |
| – | -953.0% | – | -275.0% | – | -17,071.4% | -90.8% | +15.1% | -54.8% | +88.6% | -20.0% | +142.4% | – | |
| – | – | – | – | – | – | -100.0% | – | – | -102.1% | +2,269.7% | -100.0% | – | |
| – | – | -100.0% | – | – | – | +98.4% | -100.0% | +1,790,000.0% | -105.7% | +442.0% | – | – | |
| – | – | -150.1% | – | – | – | – | -312.7% | – | -102.0% | – | – | – | |
| – | – | -1,088.0% | – | – | – | – | – | – | – | -1,489.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.